Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative
Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG...
Saved in:
Published in | Diabetes care Vol. 39; no. 12; pp. 2278 - 2287 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Diabetes Association
01.12.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD.
Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m
, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m
) or an eGFR reduction >30% and/or albuminuria.
Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m
or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders.
In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years. |
---|---|
AbstractList | Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD.
Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m
, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m
) or an eGFR reduction >30% and/or albuminuria.
Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m
or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders.
In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years. OBJECTIVE Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia -- that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels -- contributes to this high residual risk for DKD. RESEARCH DESIGN AND METHODS Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m2) or an eGFR reduction >30% and/or albuminuria. RESULTS Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m2 or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders. CONCLUSIONS In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years. Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD.OBJECTIVEDespite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD.Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m2) or an eGFR reduction >30% and/or albuminuria.RESEARCH DESIGN AND METHODSAmong a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m2) or an eGFR reduction >30% and/or albuminuria.Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m2 or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders.RESULTSOverall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m2 or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders.In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years.CONCLUSIONSIn a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years. |
Author | Viazzi, Francesca Cucinotta, Domenico Russo, Giuseppina T. Fioretto, Paola Pacilli, Antonio Genovese, Stefano Guida, Pietro Ceriello, Antonio Giorda, Carlo De Cosmo, Salvatore Pontremoli, Roberto |
Author_xml | – sequence: 1 givenname: Giuseppina T. surname: Russo fullname: Russo, Giuseppina T. organization: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy – sequence: 2 givenname: Salvatore surname: De Cosmo fullname: De Cosmo, Salvatore organization: Department of Medical Sciences, Scientific Institute “Casa Sollievo della Sofferenza,” San Giovanni Rotondo, Italy – sequence: 3 givenname: Francesca surname: Viazzi fullname: Viazzi, Francesca organization: Università degli Studi and IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genova, Italy – sequence: 4 givenname: Antonio surname: Pacilli fullname: Pacilli, Antonio organization: Department of Medical Sciences, Scientific Institute “Casa Sollievo della Sofferenza,” San Giovanni Rotondo, Italy – sequence: 5 givenname: Antonio surname: Ceriello fullname: Ceriello, Antonio organization: Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain, Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, Italy – sequence: 6 givenname: Stefano surname: Genovese fullname: Genovese, Stefano organization: Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, Italy – sequence: 7 givenname: Pietro surname: Guida fullname: Guida, Pietro organization: Associazione Medici Diabetologi, Rome, Italy – sequence: 8 givenname: Carlo surname: Giorda fullname: Giorda, Carlo organization: Diabetes and Metabolism Unit, ASL Turin 5, Chieri, Italy – sequence: 9 givenname: Domenico surname: Cucinotta fullname: Cucinotta, Domenico organization: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy – sequence: 10 givenname: Roberto surname: Pontremoli fullname: Pontremoli, Roberto organization: Università degli Studi and IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genova, Italy – sequence: 11 givenname: Paola surname: Fioretto fullname: Fioretto, Paola organization: Department of Medicine, University of Padua, Padua, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27703024$$D View this record in MEDLINE/PubMed |
BookMark | eNplkU1v1DAQhi1URLctB_4AssSFHkL9lcTmttottGIRlbqIY-TYE-pV4iy2U2n_Bz8YR91eymk0o2fe-XjP0IkfPSD0jpJPjPP6yhpaFZSJ6hVaUMXLoiyFPEELQoUqSqXYKTqLcUcIEULKN-iU1TXhhIkF-nvX6zhovA3ud38wEJyFiLW3-Ga9KVZ4A4_QR3wXwDqTcHoAvJ5L434An_DY4bXTLSRn8DdnPRxyHkFHwM7j-6ndgUkR_3LpAW8Pe8DsyEP8jLdZbPl9jZfe6zzj1rvkdHKPcIFed7kCb4_xHP38cr1d3RSbH19vV8tNYbiQqQAtSluZjrUgakYE61QntQDCqdGKVBUw1kpqoOZSaNZZaw0jDFRdd0px4Ofo45PuPox_JoipGVw00PfawzjFhkpe8lJJQjP64QW6G6cw750pUTIiOZ-p90dqagewzT64QYdD8_zvDFw9ASaMMQboGuNSvnn0KWjXN5Q0s6PN7GgzO5o7Ll90PIv-z_4D1kufHA |
CODEN | DICAD2 |
CitedBy_id | crossref_primary_10_1016_j_clnesp_2024_11_029 crossref_primary_10_1097_MD_0000000000032818 crossref_primary_10_1002_hsr2_1779 crossref_primary_10_3390_genes10100782 crossref_primary_10_1007_s11892_019_1263_x crossref_primary_10_1111_dom_13508 crossref_primary_10_1016_j_jdiacomp_2023_108585 crossref_primary_10_23876_j_krcp_22_084 crossref_primary_10_1080_00325481_2018_1481714 crossref_primary_10_3389_fmed_2025_1492483 crossref_primary_10_3390_ijms19061680 crossref_primary_10_1007_s00592_019_01375_w crossref_primary_10_1007_s40620_020_00739_8 crossref_primary_10_1016_j_jcjd_2022_04_008 crossref_primary_10_3389_fendo_2025_1503711 crossref_primary_10_1007_s44174_024_00230_z crossref_primary_10_1016_j_jdiacomp_2021_108108 crossref_primary_10_1016_j_cca_2020_05_042 crossref_primary_10_1161_ATVBAHA_121_316615 crossref_primary_10_3390_diagnostics11050871 crossref_primary_10_1186_s12882_019_1307_0 crossref_primary_10_3390_nu13061774 crossref_primary_10_1080_00325481_2019_1643633 crossref_primary_10_1210_clinem_dgaa173 crossref_primary_10_1159_000502511 crossref_primary_10_2337_dc22_0926 crossref_primary_10_1038_s41598_024_66548_2 crossref_primary_10_1155_2024_6942156 crossref_primary_10_1016_j_jacl_2024_07_004 crossref_primary_10_1016_j_jdiacomp_2022_108357 crossref_primary_10_2147_DMSO_S387726 crossref_primary_10_1016_j_pmedr_2024_102840 crossref_primary_10_1007_s10654_019_00534_1 crossref_primary_10_1186_s13098_025_01641_8 crossref_primary_10_24985_kjss_2022_33_4_543 crossref_primary_10_3390_jcm11113224 crossref_primary_10_1007_s13410_023_01243_y crossref_primary_10_1186_s12882_021_02429_4 crossref_primary_10_1186_s12944_023_01995_w crossref_primary_10_1111_dom_13449 crossref_primary_10_3389_fendo_2025_1537303 crossref_primary_10_1016_j_ejphar_2021_174121 crossref_primary_10_1111_jdi_12953 crossref_primary_10_3803_EnM_2022_1604 crossref_primary_10_1080_0886022X_2019_1655451 crossref_primary_10_3390_molecules24101866 crossref_primary_10_1007_s40620_018_00561_3 crossref_primary_10_3233_THC_230811 crossref_primary_10_2337_dc18_2062 crossref_primary_10_1016_j_ejim_2023_02_019 crossref_primary_10_7759_cureus_57777 crossref_primary_10_1136_bmjopen_2023_077808 crossref_primary_10_2147_DMSO_S481578 crossref_primary_10_1186_s12944_023_01873_5 crossref_primary_10_1155_2020_3613041 crossref_primary_10_1186_s12944_024_02308_5 crossref_primary_10_1155_2018_3450141 crossref_primary_10_1136_bmjopen_2023_073536 crossref_primary_10_1016_j_ekir_2017_03_002 crossref_primary_10_2147_DMSO_S310751 crossref_primary_10_3389_fphar_2022_1052852 crossref_primary_10_1111_nep_14044 crossref_primary_10_2337_dc19_1897 crossref_primary_10_1053_j_jrn_2024_04_002 crossref_primary_10_1136_bmjopen_2023_077338 crossref_primary_10_1016_j_jpba_2022_115028 crossref_primary_10_1159_000541510 crossref_primary_10_1016_j_mmm_2023_10_008 crossref_primary_10_4239_wjd_v12_i5_524 crossref_primary_10_7717_peerj_16915 crossref_primary_10_33549_physiolres_934533 crossref_primary_10_1186_s12944_019_0970_2 crossref_primary_10_1186_s12882_022_02932_2 crossref_primary_10_1002_dmrr_3016 crossref_primary_10_1186_s12933_022_01712_4 crossref_primary_10_1016_j_ajpath_2017_10_012 crossref_primary_10_1007_s00592_021_01765_z crossref_primary_10_1007_s12020_022_03012_z crossref_primary_10_1371_journal_pone_0311620 crossref_primary_10_1016_j_diabres_2019_107812 crossref_primary_10_2147_DMSO_S320169 crossref_primary_10_1016_j_trsl_2023_02_004 crossref_primary_10_3389_fendo_2022_1064665 crossref_primary_10_3389_fendo_2024_1331603 crossref_primary_10_1016_j_phymed_2025_156643 crossref_primary_10_1016_j_biopha_2021_111921 crossref_primary_10_17656_jsmc_10238 crossref_primary_10_3390_jcm8050755 crossref_primary_10_15406_jdmdc_2018_05_00157 crossref_primary_10_3389_fendo_2022_888599 crossref_primary_10_3390_ijms22115808 crossref_primary_10_1186_s12877_018_0732_4 crossref_primary_10_3390_genes13071158 crossref_primary_10_1155_2018_1871530 crossref_primary_10_1007_s00467_018_4104_2 crossref_primary_10_3390_jcm10112233 crossref_primary_10_1155_2019_4831459 crossref_primary_10_1177_1479164121992524 crossref_primary_10_1016_j_biopha_2023_115400 crossref_primary_10_1016_j_diabres_2022_110079 crossref_primary_10_1186_s12944_024_02003_5 crossref_primary_10_1111_dom_14502 crossref_primary_10_3390_ijms232315023 crossref_primary_10_1007_s00592_017_0983_0 crossref_primary_10_1016_j_bbrep_2024_101839 crossref_primary_10_1007_s00592_018_1194_z |
Cites_doi | 10.1161/CIRCULATIONAHA.113.002529 10.1371/journal.pone.0125512 10.1093/ndt/gft506 10.1177/1479164111407783 10.1053/j.ajkd.2007.11.010 10.1016/j.jdiacomp.2013.06.002 10.2337/db05-1620 10.1016/S0140-6736(82)91513-6 10.1046/j.1523-1755.2003.00712.x 10.1038/nrendo.2009.213 10.1093/ndt/gfs290 10.2337/diabetes.54.8.2328 10.1007/s00125-009-1597-z 10.1016/j.atherosclerosis.2005.10.018 10.1111/j.1464-5491.2010.03055.x 10.1093/ndt/gfm631 10.2337/dc10-1177 10.1016/S0272-6386(12)70171-3 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.atherosclerosis.2009.11.011 10.1007/s11892-015-0611-8 10.2337/diacare.26.2007.S94 10.1001/archinternmed.2009.471 10.1159/000095323 10.1111/joim.12026 10.1007/PL00002939 10.1093/ndt/gfv101 10.1074/jbc.M110650200 10.1097/MNH.0b013e32832f7002 10.1007/s40618-013-0023-z 10.1046/j.1523-1755.1999.07109.x 10.2337/dc12-0306 10.1007/s00125-010-1951-1 10.1093/ndt/gfr417 10.1038/ki.1993.129 10.1046/j.1523-1755.2001.00071.x |
ContentType | Journal Article |
Copyright | 2016 by the American Diabetes Association. Copyright American Diabetes Association Dec 1, 2016 |
Copyright_xml | – notice: 2016 by the American Diabetes Association. – notice: Copyright American Diabetes Association Dec 1, 2016 |
CorporateAuthor | the AMD-Annals Study Group AMD-Annals Study Group |
CorporateAuthor_xml | – name: the AMD-Annals Study Group – name: AMD-Annals Study Group |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 |
DOI | 10.2337/dc16-1246 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1935-5548 |
EndPage | 2287 |
ExternalDocumentID | 4267499701 27703024 10_2337_dc16_1246 |
Genre | Journal Article Observational Study Feature |
GroupedDBID | --- -ET ..I .XZ 08P 0R~ 18M 29F 2WC 4.4 53G 5GY 5RE 5RS 5VS 6PF 8R4 8R5 AAFWJ AAIKC AAMNW AAWTL AAYEP AAYXX ABOCM ABPPZ ACGFO ACGOD ADBBV AEGXH AENEX AERZD AFOSN AFRAH AHMBA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BENPR BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EJD EMOBN EX3 F5P GX1 H13 HZ~ IAO IEA IHR INH INR IOF IPO KQ8 L7B M0K M5~ O5R O5S O9- OK1 OVD P2P PCD Q2X RHI SV3 TDI TEORI TR2 TWZ VVN W8F WH7 WOQ WOW YHG YOC ~KM .55 .GJ 3O- 41~ 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 AAKAS AAQOH AAQQT AAYJJ ABUWG ADZCM AFFNX AFKRA AI. AN0 AQUVI ATCPS AZQEC BCR BCU BEC BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BVXVI C1A CCPQU CGR CUY CVF DWQXO ECM EIF FYUFA GNUQQ GUQSH HCIFZ HMCUK IAG ITC J5H K9- M0R M0T M1P M2O M2P M2Q N4W NAPCQ NPM PEA PHGZT PQQKQ PROAC PSQYO S0X SJFOW UKHRP VH1 WHG X7M ZCG ZGI ZXP K9. 7X8 |
ID | FETCH-LOGICAL-c348t-ea45d6cf2be472042f9f8a4e031ca9066e22b81ce7384a2fdddc202e977f993e3 |
ISSN | 0149-5992 1935-5548 |
IngestDate | Fri Jul 11 07:29:40 EDT 2025 Mon Jun 30 16:59:48 EDT 2025 Tue Apr 08 05:56:58 EDT 2025 Tue Jul 01 04:11:50 EDT 2025 Thu Apr 24 23:10:33 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | 2016 by the American Diabetes Association. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c348t-ea45d6cf2be472042f9f8a4e031ca9066e22b81ce7384a2fdddc202e977f993e3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://care.diabetesjournals.org/content/diacare/39/12/2278.full.pdf |
PMID | 27703024 |
PQID | 1845208331 |
PQPubID | 47715 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1835359801 proquest_journals_1845208331 pubmed_primary_27703024 crossref_citationtrail_10_2337_dc16_1246 crossref_primary_10_2337_dc16_1246 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-12-01 |
PublicationDateYYYYMMDD | 2016-12-01 |
PublicationDate_xml | – month: 12 year: 2016 text: 2016-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Alexandria |
PublicationTitle | Diabetes care |
PublicationTitleAlternate | Diabetes Care |
PublicationYear | 2016 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | Hermans (2022031222253703500_B17) 2011; 8 Adler (2022031222253703500_B26) 2003; 63 De Cosmo (2022031222253703500_B24) 2015; 30 De Cosmo (2022031222253703500_B32) 2013; 28 Jenkins (2022031222253703500_B35) 2013; 27 Asztalos (2022031222253703500_B27) 2006; 188 Hanai (2022031222253703500_B38) 2012; 27 Stadler (2022031222253703500_B39) 2015; 15 Fioretto (2022031222253703500_B3) 2010; 6 Colhoun (2022031222253703500_B1) 2001; 44 Jandeleit-Dahm (2022031222253703500_B6) 1999; 71 Nicolucci (2022031222253703500_B22) 2010; 27 Schlondorff (2022031222253703500_B13) 1993; 22 Jauregui (2022031222253703500_B33) 2009; 18 Zhou (2022031222253703500_B31) 2008; 23 Wang (2022031222253703500_B7) 2005; 54 Moorhead (2022031222253703500_B5) 1982; 2 Zager (2022031222253703500_B11) 2001; 60 Levey (2022031222253703500_B25) 2009; 150 Russo (2022031222253703500_B29) 2014 De Cosmo (2022031222253703500_B23) 2014; 29 Sun (2022031222253703500_B8) 2002; 277 Lin (2022031222253703500_B20) 2010; 53 Sacks (2022031222253703500_B21) 2014; 129 Penno (2022031222253703500_B37) 2015; 10 Molitch (2022031222253703500_B4) 2003; 26 Takemura (2022031222253703500_B12) 1993; 43 Tsun (2022031222253703500_B14) 2014 Mäkinen (2022031222253703500_B36) 2013; 273 Gröne (2022031222253703500_B10) 1996; 54 Salardi (2022031222253703500_B34) 2011; 34 Russo (2022031222253703500_B30) 2014; 37 Retnakaran (2022031222253703500_B2) 2006; 55 Han (2022031222253703500_B40) 2016 Tu (2022031222253703500_B18) 2010; 170 Russo (2022031222253703500_B28) 2010; 210 Xu (2022031222253703500_B19) 2008; 51 Morton (2022031222253703500_B15) 2012; 35 Abrass (2022031222253703500_B9) 2006; 151 Davis (2022031222253703500_B16) 2011; 54 |
References_xml | – volume: 129 start-page: 999 year: 2014 ident: 2022031222253703500_B21 article-title: Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.002529 – volume: 10 start-page: e0125512 year: 2015 ident: 2022031222253703500_B37 article-title: Hypertriglyceridemia is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study publication-title: PLoS One doi: 10.1371/journal.pone.0125512 – volume: 29 start-page: 657 year: 2014 ident: 2022031222253703500_B23 article-title: Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gft506 – volume: 8 start-page: 180 year: 2011 ident: 2022031222253703500_B17 article-title: Non-invited review: prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD publication-title: Diab Vasc Dis Res doi: 10.1177/1479164111407783 – start-page: 607924 volume-title: Int J Endocrinol year: 2014 ident: 2022031222253703500_B29 article-title: Markers of systemic inflammation and Apo-AI containing HDL subpopulations in women with and without diabetes – volume: 51 start-page: 415 year: 2008 ident: 2022031222253703500_B19 article-title: A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2007.11.010 – volume: 27 start-page: 447 year: 2013 ident: 2022031222253703500_B35 article-title: Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort publication-title: J Diabetes Complications doi: 10.1016/j.jdiacomp.2013.06.002 – volume: 55 start-page: 1832 year: 2006 ident: 2022031222253703500_B2 article-title: Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74 publication-title: Diabetes doi: 10.2337/db05-1620 – volume: 2 start-page: 1309 year: 1982 ident: 2022031222253703500_B5 article-title: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease publication-title: Lancet doi: 10.1016/S0140-6736(82)91513-6 – volume: 63 start-page: 225 year: 2003 ident: 2022031222253703500_B26 article-title: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00712.x – volume: 6 start-page: 19 year: 2010 ident: 2022031222253703500_B3 article-title: Residual microvascular risk in diabetes: unmet needs and future directions publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2009.213 – start-page: e0154683 volume-title: PLoS One year: 2016 ident: 2022031222253703500_B40 article-title: Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia – volume: 28 start-page: 29 year: 2013 ident: 2022031222253703500_B32 article-title: Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfs290 – volume: 54 start-page: 2328 year: 2005 ident: 2022031222253703500_B7 article-title: Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.54.8.2328 – volume: 53 start-page: 263 year: 2010 ident: 2022031222253703500_B20 article-title: Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-009-1597-z – volume: 188 start-page: 59 year: 2006 ident: 2022031222253703500_B27 article-title: LpA-I, LpA-I:A-II HDL and CHD-risk: the Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.10.018 – volume: 27 start-page: 1041 year: 2010 ident: 2022031222253703500_B22 article-title: Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative publication-title: Diabet Med doi: 10.1111/j.1464-5491.2010.03055.x – volume: 23 start-page: 927 year: 2008 ident: 2022031222253703500_B31 article-title: Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfm631 – volume: 34 start-page: 424 year: 2011 ident: 2022031222253703500_B34 article-title: High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol publication-title: Diabetes Care doi: 10.2337/dc10-1177 – volume: 22 start-page: 72 year: 1993 ident: 2022031222253703500_B13 article-title: Cellular mechanisms of lipid injury in the glomerulus publication-title: Am J Kidney Dis doi: 10.1016/S0272-6386(12)70171-3 – volume: 150 start-page: 604 year: 2009 ident: 2022031222253703500_B25 article-title: A new equation to estimate glomerular filtration rate publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 – volume: 210 start-page: 294 year: 2010 ident: 2022031222253703500_B28 article-title: Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2009.11.011 – volume: 15 start-page: 40 year: 2015 ident: 2022031222253703500_B39 article-title: The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease publication-title: Curr Diab Rep doi: 10.1007/s11892-015-0611-8 – volume: 26 start-page: S94 year: 2003 ident: 2022031222253703500_B4 article-title: Diabetic nephropathy publication-title: Diabetes Care doi: 10.2337/diacare.26.2007.S94 – volume: 170 start-page: 155 year: 2010 ident: 2022031222253703500_B18 article-title: Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis publication-title: Arch Intern Med doi: 10.1001/archinternmed.2009.471 – volume: 151 start-page: 106 year: 2006 ident: 2022031222253703500_B9 article-title: Lipid metabolism and renal disease publication-title: Contrib Nephrol doi: 10.1159/000095323 – volume: 273 start-page: 383 year: 2013 ident: 2022031222253703500_B36 article-title: Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study publication-title: J Intern Med doi: 10.1111/joim.12026 – start-page: e105787 volume-title: PLoS One year: 2014 ident: 2022031222253703500_B14 article-title: Cellular cholesterol transport proteins in diabetic nephropathy – volume: 44 start-page: S46 year: 2001 ident: 2022031222253703500_B1 article-title: Risk factors for renal failure: the WHO Mulitnational Study of Vascular Disease in Diabetes publication-title: Diabetologia doi: 10.1007/PL00002939 – volume: 30 start-page: 1526 year: 2015 ident: 2022031222253703500_B24 article-title: Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfv101 – volume: 277 start-page: 18919 year: 2002 ident: 2022031222253703500_B8 article-title: Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus publication-title: J Biol Chem doi: 10.1074/jbc.M110650200 – volume: 18 start-page: 539 year: 2009 ident: 2022031222253703500_B33 article-title: Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria publication-title: Curr Opin Nephrol Hypertens doi: 10.1097/MNH.0b013e32832f7002 – volume: 37 start-page: 261 year: 2014 ident: 2022031222253703500_B30 article-title: Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease publication-title: J Endocrinol Invest doi: 10.1007/s40618-013-0023-z – volume: 71 start-page: S31 year: 1999 ident: 2022031222253703500_B6 article-title: Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy publication-title: Kidney Int Suppl doi: 10.1046/j.1523-1755.1999.07109.x – volume: 54 start-page: S18 year: 1996 ident: 2022031222253703500_B10 article-title: Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins publication-title: Kidney Int Suppl – volume: 35 start-page: 2201 year: 2012 ident: 2022031222253703500_B15 article-title: Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study publication-title: Diabetes Care doi: 10.2337/dc12-0306 – volume: 54 start-page: 280 year: 2011 ident: 2022031222253703500_B16 article-title: Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study publication-title: Diabetologia doi: 10.1007/s00125-010-1951-1 – volume: 27 start-page: 1070 year: 2012 ident: 2022031222253703500_B38 article-title: Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfr417 – volume: 43 start-page: 918 year: 1993 ident: 2022031222253703500_B12 article-title: Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases publication-title: Kidney Int doi: 10.1038/ki.1993.129 – volume: 60 start-page: 2299 year: 2001 ident: 2022031222253703500_B11 article-title: Renal cortical cholesterol accumulation is an integral component of the systemic stress response publication-title: Kidney Int doi: 10.1046/j.1523-1755.2001.00071.x |
SSID | ssj0004488 |
Score | 2.5348403 |
Snippet | Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among... OBJECTIVE Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 2278 |
SubjectTerms | Aged Albuminuria - blood Albuminuria - diagnosis Albuminuria - epidemiology Blood Glucose - metabolism Blood Pressure Cholesterol, HDL - blood Cholesterol, LDL - blood Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - epidemiology Diabetic Nephropathies - blood Diabetic Nephropathies - diagnosis Diabetic Nephropathies - epidemiology Diabetic Nephropathies - physiopathology Dyslipidemias - blood Dyslipidemias - complications Dyslipidemias - diagnosis Dyslipidemias - epidemiology Female Glucose Humans Incidence Italy - epidemiology Low density lipoprotein Male Middle Aged Prognosis Retrospective Studies Risk Factors Triglycerides - blood |
Title | Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27703024 https://www.proquest.com/docview/1845208331 https://www.proquest.com/docview/1835359801 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fi9NAEF7qCeKLnD-v3imj-CCUaLPZpBvfilWqZ0Whp_cWtpsNRNr0sK1g_w4f_WOd2c2mueMO1JcQkt0sZL6dzEy-mWHsWZjrOBJGBkkhdCCU6AdK4HY3OjWxSmU0s3lrk4_J-ES8P41PO53fLdbSZj17obeX5pX8j1TxGsqVsmT_QbLNQ_ECnqN88YgSxuNfyfgTmr4L1Zuihz3_qXHF3LiSy-PRhwD9bSIErYhlkZfa5iy2OUJkJjo-TKl7x2VeoXYYud81FARBjfLNMj2-UqR26iK1NX9m5bkaw8moV5dgfkcsJOWTNr296yfYCtjNz50NvhcbkC83K0MFItSOqz2iPnqrxdKFq-c_KCjQzPxSqu229AY3qrgd0YjYhXOX6z2kvsiOX-YDGmHSIocYp4TTKA7QzJFtLe1KHnk08rbO5a4J0MWPAY9sOYFc2yVcoLMFirOFRQUfkM5zedwXKm_7W9fYdTzl1B_j-HOrFj3qPlerilZ62axD9aXrmeeNnSs8GGvJTPfZrdoFgaHD023WMdUddmNSkyzusl8OVnAOVoCwAgsrcLCCGlaAsIIWrGBZgIcVOFhBDSsoK_CwAoIVEKyAg0fJK0BQAYIKHKhgB6p77OTtm-nrcVA37wh0JOQ6MErEeaILPjOCGiHxIi2kEgY_IlqlaOgazmcy1GYQSaF4kee55n1u0B8p0GY20X22Vy0rc8Agz5NU4ZdbKTMgD1_Ggod9mcokpTTvqMue-7ec6bqyPTVYmWfo4ZJsMpJNRrLpsqfN0DNXzuWyQUdeVFm921dZKEXM0V-Jwi570txGXUw_2FRllhsaE8VUEbOPYx44ETereEg8vPLOIbu52w5HbG_9fWMeocW7nj22wPsDGKGrJw |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+Triglycerides+and+HDL-C+Levels+Predict+the+Development+of+Diabetic+Kidney+Disease+in+Subjects+With+Type+2+Diabetes%3A+The+AMD+Annals+Initiative&rft.jtitle=Diabetes+care&rft.au=Russo%2C+Giuseppina+T&rft.au=De+Cosmo%2C+Salvatore&rft.au=Viazzi%2C+Francesca&rft.au=Pacilli%2C+Antonio&rft.date=2016-12-01&rft.eissn=1935-5548&rft.volume=39&rft.issue=12&rft.spage=2278&rft_id=info:doi/10.2337%2Fdc16-1246&rft_id=info%3Apmid%2F27703024&rft.externalDocID=27703024 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |